Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yuan Zhi is an analyst at B. Riley Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/31/2024 | CYRX | Buy Now | CryoPort | $9.22 | 62.69% | $19 → $15 | Upgrade | Neutral → Buy | Get Alert |
| 05/15/2024 | CTSO | Buy Now | CytoSorbents | $1.22 | 145.9% | → $3 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | CYRX | Buy Now | CryoPort | $9.22 | 106.07% | $22 → $19 | Downgrade | Buy → Neutral | Get Alert |
| 04/09/2024 | CATX | Buy Now | Perspective Therapeutics | $12.99 | -86.91% | $12 → $17 | Maintains | Buy | Get Alert |
| 03/20/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $13 → $23 | Downgrade | Buy → Neutral | Get Alert |
| 03/18/2024 | AGEN | Buy Now | Agenus | $6.16 | -18.82% | $120 → $100 | Maintains | Buy | Get Alert |
| 02/01/2024 | AZTA | Buy Now | Azenta | $62.83 | 25.74% | $61 → $79 | Maintains | Buy | Get Alert |
| 01/26/2024 | CATX | Buy Now | Perspective Therapeutics | $12.99 | -90.76% | → $12 | Initiates | → Buy | Get Alert |
| 01/09/2024 | AMAM | Buy Now | Ambrx Biopharma | — | — | $26 → $28 | Downgrade | Buy → Neutral | Get Alert |
| 12/11/2023 | ATNM | Buy Now | Actinium Pharma | $7.00 | 128.45% | $20 → $16 | Maintains | Buy | Get Alert |
| 12/08/2023 | TNGX | Buy Now | Tango Therapeutics | $9.70 | 64.95% | → $16 | Initiates | → Buy | Get Alert |
| 10/03/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $13 | Reiterates | Buy → Buy | Get Alert |
| 10/03/2023 | ATNM | Buy Now | Actinium Pharma | $7.00 | 185.56% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 07/13/2023 | CYRX | Buy Now | CryoPort | $9.22 | 138.61% | $30 → $22 | Maintains | Buy | Get Alert |
| 06/14/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $26 | Initiates | → Buy | Get Alert |
| 03/30/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $10 | Reiterates | → Buy | Get Alert |
| 02/21/2023 | ISEE | Buy Now | IVERIC bio | — | — | $17 → $19 | Maintains | Neutral | Get Alert |
| 02/10/2023 | AZTA | Buy Now | Azenta | $62.83 | 8.23% | $77 → $68 | Maintains | Buy | Get Alert |
| 12/01/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $10 | Reinstates | → Buy | Get Alert |
| 11/16/2022 | CYRX | Buy Now | CryoPort | $9.22 | 225.38% | $55 → $30 | Maintains | Buy | Get Alert |
| 10/31/2022 | ATNM | Buy Now | Actinium Pharma | $7.00 | 157.01% | $16 → $18 | Maintains | Buy | Get Alert |
| 09/06/2022 | ISEE | Buy Now | IVERIC bio | — | — | $12 → $8 | Downgrade | Neutral → Sell | Get Alert |
| 08/25/2022 | ATNM | Buy Now | Actinium Pharma | $7.00 | 128.45% | → $16 | Initiates | → Buy | Get Alert |
| 05/17/2022 | AZTA | Buy Now | Azenta | $62.83 | 49.61% | $106 → $94 | Maintains | Buy | Get Alert |
| 05/12/2022 | ISEE | Buy Now | IVERIC bio | — | — | → $12 | Initiates | → Neutral | Get Alert |
